Cocaine Rehab Cost in New York: Contingency Management, Pricing, and 2026 Reality
Cocaine rehab in New York costs $20,000 to $58,000 for a 30-day inpatient program without insurance, or $7,500 to $21,000 out-of-pocket with PPO insurance. Unlike opioids and alcohol, cocaine use disorder has no FDA-approved medication — contingency management (CM) is the most evidence-based treatment, increasingly covered by NY commercial insurers and NY Medicaid. Fentanyl is increasingly contaminating the NY cocaine supply, posing lethal risk to stimulant-only users with no opioid tolerance. NY Medicaid covers the full continuum at $0 for 7.5 million enrollees; Timothy’s Law protects commercial coverage.
Cocaine use disorder treatment in New York in 2026 sits at an inflection point. The absence of FDA-approved MAT is a real clinical limitation, but contingency management has emerged as an evidence-based intervention with strong outcomes. New York’s 2006–2024 policy infrastructure (Timothy’s Law, Article 49, 2024 Medicaid reimbursement parity expansion) increasingly supports CM coverage and ASAM-aligned medical necessity. Fentanyl contamination of the cocaine supply has added overdose risk requiring harm-reduction integration. This guide combines NY-specific clinical reality with the 2006–2024 policy stack.
The NY Cocaine Reality: No MAT, But CM Works
The clinical honesty competitors avoid: there is no FDA-approved medication for cocaine use disorder as of 2026. Unlike opioid use disorder (buprenorphine, methadone, Vivitrol) or alcohol use disorder (naltrexone, acamprosate, disulfiram), stimulant use disorder has no pharmacologic mainstay.
What Works: Contingency Management
Contingency management (CM) is a behavioral intervention that provides small tangible incentives (gift cards, vouchers, prize drawings) contingent on negative drug tests or treatment attendance. Evidence base:
- Retention rates 70%+ in some studies
- Medium-to-large effect sizes on abstinence in meta-analyses
- Strongest psychosocial evidence of any cocaine intervention
- Works by providing an alternative reward pathway to reinforce abstinence
CM Availability in New York
- OASAS-certified providers increasingly offer CM — ask specifically
- Mount Sinai REACH, Columbia COMPASS, NYU CAMP, Weill Cornell — academic addiction programs with CM
- NYC Health + Hospitals offers CM at select sites
- NY Medicaid coverage of CM for stimulant UD is expanding
- Under Timothy’s Law + 2024 MHPAEA final rule, commercial insurers face increasing pressure to cover CM
Off-Label Pharmacotherapy Being Studied at NY Academic Centers
- Topiramate — modest evidence for reducing cocaine use
- Bupropion — useful especially with co-occurring depression
- Modafinil — studied at Mount Sinai, Columbia, NYU
- Naltrexone + bupropion combination — early evidence
- Disulfiram — dopamine metabolism effects; studied for cocaine
Mount Sinai, Columbia, NYU, Weill Cornell, and Albert Einstein academic centers offer clinical trials providing free access to experimental medications.
Why New York Is Different for Cocaine Treatment
1. Timothy’s Law (2006)
NY’s parity law requires group insurers to cover SUD treatment at parity with medical — including stimulant UD. See rehab cost in New York.
2. 2024 NY Medicaid Reimbursement Parity Expansion
Commercial insurers must pay OASAS-certified providers at Medicaid-minimum rates — expanded commercial in-network stimulant treatment.
3. OASAS Stimulant Treatment Network
NY has dedicated stimulant UD treatment capacity within the OASAS provider network and NYC Health + Hospitals system.
4. Strong NY Academic Addiction Medicine Programs
Mount Sinai REACH, Columbia COMPASS, NYU CAMP, Weill Cornell — leading research into cocaine pharmacotherapy and CM.
5. NYC DOHMH Fentanyl Contamination Response
Extensive fentanyl test strip distribution, naloxone saturation, and public health alerts protect stimulant-only users.
6. NY Opioid Settlement Fund
Some allocation has gone to stimulant UD treatment capacity given rising polysubstance use patterns.
For full NY regulatory context, see rehab cost in New York. For cocaine-specific clinical treatment nationally, see cocaine rehab cost.
Cocaine Rehab Cost in NY: 2026 Breakdown
| Level of Care | Duration | Without Insurance | With PPO |
|---|---|---|---|
| Medical observation / crash monitoring | 5–7 days | $1,000 – $3,500 | $500 – $2,450 |
| Inpatient residential (standard) | 30 days | $20,000 – $35,000 | $7,500 – $14,000 |
| Inpatient residential (mid-tier) | 30 days | $30,000 – $46,000 | $10,000 – $18,000 |
| Manhattan / Long Island luxury | 30 days | $50,000 – $100,000+ | Capped at OOP max |
| Partial hospitalization (PHP) | 4–6 weeks | $6,000 – $20,000 | Capped at OOP max |
| Intensive outpatient with CM | 8–12 weeks | $3,000 – $12,000 | Capped at OOP max |
| Standard outpatient with CM | 6–12 months | $2,000 – $7,500 | Capped at OOP max |
| Contingency management incentives | 12–24 weeks | $300 – $1,000 total | Increasingly covered |
NY Medicaid covers all of the above at $0 for eligible New Yorkers.
Fentanyl-Contaminated Cocaine: A Rising NY Threat
NYC DOHMH drug supply surveillance and DEA 2024 data show rising fentanyl contamination of the cocaine supply. While detection rates in cocaine remain lower than in heroin (which is approaching 100% fentanyl-contaminated in NY), the trend is worrisome.
Why It’s Especially Dangerous
Cocaine users typically have no opioid tolerance. A fentanyl-laced bag can cause fatal respiratory depression at doses a tolerant opioid user would survive. NY overdose data indicate fentanyl increasingly appears in stimulant-only users — people who don’t use opioids but die from fentanyl-laced cocaine.
NYC DOHMH Harm Reduction Response
- NYC DOHMH fentanyl test strip distribution — free, via syringe services, community orgs, harm reduction outreach
- Naloxone saturation — free via pharmacies (no prescription required at participating pharmacies), syringe services, community orgs
- Public health alerts — CDC, NYC DOHMH, NY DOH
- OnPoint NYC overdose prevention centers — supervised consumption with naloxone on standby
- Education that any cocaine may contain fentanyl
Treatment Planning Implications
Cocaine patients with any history of using fentanyl-contaminated cocaine are effectively dual-substance patients. NY treatment programs increasingly screen for both stimulant and opioid use disorder; patients with polysubstance use often benefit from opioid MAT (naltrexone/Vivitrol, or buprenorphine if OUD pattern detected) alongside CM and CBT for the stimulant component.
For full fentanyl mechanics in NY, see fentanyl rehab cost in New York.
Cocaine Withdrawal and the “Crash”
Cocaine withdrawal is not medically dangerous in the way alcohol or benzodiazepine withdrawal is — but it is psychologically intense and drives high relapse rates without structured support.
Timeline
| Phase | Duration | Clinical Picture |
|---|---|---|
| Crash | 24–72 hours | Fatigue, depression, increased appetite, hypersomnia |
| Acute withdrawal | 1–2 weeks | Anhedonia, cravings, sleep disturbance, depression |
| Subacute | 2–10 weeks | Cravings persist, mood stabilizing |
| PAWS | Months | Episodic cravings, intermittent mood changes |
What Detox Includes in NY
- 24/7 nursing observation
- Psychiatric assessment for suicidality (crash-phase depression can be severe)
- Sleep aids (trazodone, hydroxyzine)
- Nutritional support
- Hydration and electrolyte repletion
- Screening for cardiac complications (cocaine can cause MI, arrhythmia, cardiomyopathy)
- Treatment of co-occurring substances (alcohol, opioid if polysubstance)
- Warm handoff to residential or outpatient with CM
Contingency Management Programs in NY
OASAS-Certified Providers
Ask OASAS-certified outpatient providers whether they offer CM. The 2024 Medicaid reimbursement parity expansion expanded commercial-network OASAS providers.
NY Academic Addiction Medicine Programs
- Mount Sinai REACH Addiction Medicine — CM + CBT + off-label pharmacotherapy trials
- Columbia COMPASS — research-grade CM programs
- NYU CAMP (Comprehensive Addiction Management Program) — CM + dual-diagnosis integration
- Weill Cornell Addiction Medicine — CM + pharmacotherapy trials
- Albert Einstein College of Medicine — addiction research programs
NY Medicaid CM Coverage
NY Medicaid coverage of CM for stimulant UD is expanding — though not yet as broad as California’s Recovery Incentives pilot. Ask providers directly about coverage status.
Commercial Insurance CM
Under Timothy’s Law + the 2024 MHPAEA final rule, commercial insurers are expected to cover CM as evidence-based treatment. Coverage varies by plan.
Polysubstance Treatment: The NY Reality
Most NY cocaine patients are not only cocaine patients. Common polysubstance patterns:
- Cocaine + alcohol — the “speedball” concept; simultaneous stimulant + depressant; high cardiac risk
- Cocaine + opioid — classic speedball; fentanyl contamination heightens risk
- Cocaine + fentanyl contamination — unintentional opioid exposure in stimulant-only users
- Cocaine + benzo — managing cocaine anxiety; benzo adds overdose risk
- Counterfeit pressed pills — fake Percocet/Xanax increasingly pressed with fentanyl
NY treatment programs have integrated polysubstance approaches: simultaneous CM for stimulants, alcohol MAT if AUD pattern (naltrexone/Vivitrol, acamprosate), opioid MAT if OUD detected (buprenorphine, Brixadi, Vivitrol), and treatment of co-occurring psychiatric conditions.
Cocaine Treatment Length in NY
Evidence-based sequence:
- Medical observation / crash support (5–7 days)
- Residential or PHP (30–90 days)
- IOP with contingency management (8–12 weeks)
- Standard outpatient with continued CM (6–12 months)
- Recovery support and co-occurring treatment (ongoing)
NIDA recommends minimum 90 days structured care. Under Timothy’s Law, NY insurers cannot impose arbitrary day caps. CM effectiveness peaks in the first 12–24 weeks of active intervention.
How Do New Yorkers Afford Cocaine Rehab?
1. NY Medicaid (7.5 million enrollees)
Full continuum at $0.
2. Private Commercial Insurance
Empire BCBS, Excellus BCBS, Highmark, Fidelis, UnitedHealthcare, Aetna, Cigna, Oscar. Capped at $7,000–$9,500 OOP max.
3. NY State of Health Marketplace
Subsidized premiums from $20/month under IRA-enhanced subsidies.
4. OASAS Addiction Treatment Centers
12 directly-operated ATCs — free or sliding scale.
5. NYC Health + Hospitals
Free stimulant treatment regardless of insurance for NYC residents.
6. Faith-Based and Sliding-Scale
Salvation Army ARCs, 60+ FQHCs.
7. NY Opioid Settlement Fund–Supported Services
Some stimulant UD expansion through the Fund.
Choosing a New York Cocaine Rehab
Verification questions before admission:
- Is the facility in-network for my plan?
- Do you offer contingency management?
- Are you OASAS-certified (relevant for 2024 Medicaid reimbursement parity expansion)?
- How do you handle polysubstance use?
- Do you screen for fentanyl contamination exposure?
- Under Timothy’s Law, confirm no arbitrary day caps on residential treatment
- What’s the outpatient / IOP continuation plan?
- What’s my deductible and OOP max, and what’s met year-to-date?
New York Cocaine Resources
State and City Resources
- NYS HOPELINE: 1-877-846-7369 (24/7)
- OASAS: oasas.ny.gov
- NYC DOHMH: nyc.gov/health
- SAMHSA National Helpline: 1-800-662-4357
- 988 Suicide & Crisis Lifeline: 988
- NY State of Health: nystateofhealth.ny.gov
Harm Reduction
- NYC DOHMH fentanyl test strip distribution — free, via syringe services
- NYC DOHMH Naloxone Saturation Program — free naloxone
- OnPoint NYC — overdose prevention centers
- NY Harm Reduction Coalition — nyhrc.org
Major NY Counties
- NYC DOHMH referral line: 311
- Westchester DCMH: 1-914-813-5000
- Nassau Mental Health: 1-516-227-9471
- Suffolk DCMH: 1-631-853-8500
- Erie County (Buffalo): 716-858-8500
- Monroe County (Rochester): 1-800-899-1265
- Albany County BHS: 1-518-447-4555
Support Groups
- Cocaine Anonymous New York — active meetings
- AA New York Intergroup: 4,000+ NYC meetings for co-occurring alcohol
- SMART Recovery NY — science-based alternative
- LifeRing Secular Recovery NY — secular group-based
Final Thoughts
New York cocaine treatment in 2026 faces the clinical limitation of no FDA-approved MAT, balanced by expanding access to evidence-based contingency management and the strongest layered parity protection in the nation (Timothy’s Law + 2024 Medicaid reimbursement parity + federal MHPAEA final rule). Fentanyl contamination of the cocaine supply adds lethal overdose risk requiring harm-reduction integration — stimulant-only users have no opioid tolerance.
Five steps:
- Check NY Medicaid eligibility — 7.5 million qualify for $0 comprehensive coverage
- Ask about contingency management at the admitting facility
- Screen for polysubstance use — most NY cocaine patients also use alcohol / opioid
- Carry naloxone and use fentanyl test strips if at risk for fentanyl contamination
- Verify private insurance — Timothy’s Law + 2024 parity expansion
For broader context, see rehab cost in New York, cocaine rehab cost, alcohol rehab cost in New York (polysubstance context), fentanyl rehab cost in New York, and medical detox cost.
Sources
- NYC Department of Health and Mental Hygiene. “Drug Supply Surveillance.” 2023–2024.
- Drug Enforcement Administration. “National Drug Threat Assessment.” 2024.
- National Institute on Drug Abuse. “Cocaine Research Report.” 2024.
- New York State Timothy’s Law (2006).
- NY 2024 Medicaid Reimbursement Parity Expansion.
- Higgins ST, et al. “Contingency Management for Stimulant Use Disorder: A Systematic Review.” Addiction. 2024.
- American Society of Addiction Medicine. “Clinical Guidance on Stimulant Use Disorder.” 2023.
- U.S. Department of Labor. “Mental Health Parity and Addiction Equity Act Final Rule (September 2024).” https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-and-substance-use-disorder-parity
- NY OASAS. “Provider Directory.” 2025. https://oasas.ny.gov/
- NYC DOHMH. “Fentanyl Test Strip Distribution.” 2024.
- Mount Sinai REACH Addiction Medicine. “Stimulant Use Disorder Treatment Research.” 2024.
- Columbia COMPASS. “Cocaine Pharmacotherapy Trials.” 2024.
- SAMHSA Behavioral Health Treatment Services Locator. 2025. https://findtreatment.samhsa.gov/
Cocaine Treatment in New York — Is Your Plan Enough?
Even with insurance, many people discover their plan doesn't cover residential treatment at the level they need. A broker who specializes in behavioral health coverage can review your situation and find a plan that works.
Call 1-866-454-9577Free Consultation · No Obligation
Prodest Insurance Group is a licensed, independent health insurance brokerage. Calling the number above connects you with a licensed insurance agent, not a treatment facility. Insurance placement is a separate service from treatment referral.
Frequently Asked Questions
How much does cocaine rehab cost in New York?
Cocaine rehab in New York costs $20,000–$58,000 for 30 days of inpatient treatment without insurance, or $7,500–$21,000 out-of-pocket with PPO insurance (capped at the 2026 OOP max of $7,000–$9,500). Detox typically runs 5–7 days and is shorter than for alcohol, opioids, or benzodiazepines because cocaine withdrawal is primarily psychological — cravings, depression, fatigue, sleep disturbance — rather than medically dangerous. Contingency management (CM), the most evidence-based treatment for cocaine use disorder, is increasingly covered by NY commercial insurers and NY Medicaid. Ongoing outpatient or IOP runs $1,500–$5,000/month insured, or $0 with NY Medicaid. Manhattan and Long Island luxury programs run $50,000–$100,000+.
Is there FDA-approved medication for cocaine addiction?
No. As of 2026, there is no FDA-approved medication-assisted treatment specifically for cocaine use disorder. This distinguishes cocaine treatment from opioid and alcohol treatment, where multiple MAT options exist. What New York clinicians use instead: (1) contingency management (CM) as the gold-standard evidence-based intervention — patients earn small rewards for negative drug tests with retention rates reaching 70%+ in some studies; (2) cognitive behavioral therapy (CBT) and motivational interviewing; (3) off-label pharmacotherapy being actively studied at NY academic centers (Mount Sinai, Columbia, NYU, Weill Cornell) — topiramate, bupropion, modafinil, naltrexone + bupropion combination; (4) treatment of co-occurring depression, anxiety, or ADHD that often drives stimulant use. NY's Opioid Settlement Fund has allocated some resources to stimulant use disorder expansion.
Does NY Medicaid cover cocaine rehab?
Yes, comprehensively. NY Medicaid covers the full cocaine use disorder treatment continuum at $0 cost for 7.5 million enrollees: medical observation/withdrawal support (5–7 days), inpatient residential treatment, PHP, IOP, standard outpatient, and evidence-based psychotherapies (CBT, MI, some CM programs). NY Medicaid coverage of contingency management for stimulant use disorder is expanding — though not yet as broad as California's Recovery Incentives pilot. The 2024 NY Medicaid reimbursement parity expansion requires commercial insurers to pay OASAS-certified providers at Medicaid-minimum rates, expanding the in-network provider pool for all New Yorkers. Apply for NY Medicaid at NY State of Health or county social services.
What is contingency management and does it work for cocaine?
Contingency management (CM) is an evidence-based behavioral treatment that provides small tangible incentives (gift cards, vouchers, prize drawings) contingent on negative drug tests or attendance at treatment sessions. For stimulant use disorder specifically, CM has the strongest evidence base of any psychosocial intervention — retention rates reach 70%+ in some studies, with meta-analyses showing medium-to-large effect sizes on abstinence. The mechanism: substance use hijacks the brain's reward system; CM provides an alternative reward pathway that reinforces abstinence. New York's OASAS-certified providers increasingly offer CM, and commercial insurers under Timothy's Law + the 2024 MHPAEA final rule are expected to cover CM as evidence-based treatment. Mount Sinai REACH, Columbia, NYU, and Weill Cornell addiction medicine programs offer CM. Ask facilities and outpatient providers whether CM is offered.
Is cocaine contaminated with fentanyl in New York?
Yes, and the trend is rising. NYC DOHMH drug supply surveillance and DEA 2024 data show increasing fentanyl contamination of the NY cocaine supply. Fentanyl-contaminated cocaine is especially dangerous because cocaine users typically have no opioid tolerance — a fentanyl-laced bag can cause fatal respiratory depression at doses a tolerant opioid user would survive. NY overdose data indicate fentanyl is increasingly appearing in stimulant-only users (people who don't use opioids but die from fentanyl-laced cocaine). Harm reduction response: (1) NYC DOHMH distributes fentanyl test strips widely — many strips detect both fentanyl and xylazine; (2) naloxone distribution through the NYC Naloxone Saturation Program; (3) public health alerts from CDC, NYC DOHMH, and NY DOH; (4) education that any cocaine — including powder — may contain fentanyl; (5) OnPoint NYC overdose prevention centers provide supervised consumption with naloxone on standby.
How is NY handling cocaine and polysubstance use?
New York has expanded stimulant use disorder treatment capacity since 2022, particularly through OASAS provider network growth and the 2024 Medicaid reimbursement parity expansion that broadened commercial in-network options. Polysubstance reality: most NY cocaine patients also use alcohol, other substances, and increasingly fentanyl (intentionally or via contamination). NY treatment programs have integrated polysubstance treatment approaches — simultaneous CM for stimulants, alcohol MAT if AUD co-occurs (naltrexone/Vivitrol, acamprosate), opioid MAT if OUD detected (buprenorphine, Brixadi, Vivitrol), and treatment of co-occurring psychiatric conditions. The NY Opioid Settlement Fund has allocated some resources to stimulant UD treatment capacity expansion as polysubstance use increasingly includes cocaine.
How long does cocaine rehab take in New York?
Cocaine treatment duration varies based on severity. Typical evidence-based sequence in New York: 5–7 day medical observation/crash support (cocaine withdrawal is not medically dangerous but intense depression and cravings require monitoring), 30–90 day residential or PHP, 8–12 week IOP with contingency management, and 6–12 months standard outpatient with continued CM. NIDA recommends minimum 90 days of structured care. Under Timothy's Law + Article 49, NY insurers cannot impose arbitrary day caps. The 2024 Medicaid reimbursement parity expansion expanded commercial-network OASAS-certified outpatient stimulant treatment. CM effectiveness peaks in the first 12–24 weeks of active intervention; most patients benefit from extended outpatient and recovery support — stimulant UD is a chronic condition like other SUDs.
What off-label medications are being studied for cocaine at NY academic centers?
Several medications are being actively studied at New York academic centers for cocaine use disorder, though none are FDA-approved for this indication as of 2026. Agents with some evidence: (1) topiramate — anticonvulsant, modest evidence for reducing cocaine use; (2) bupropion — antidepressant, useful especially for depression + cocaine co-occurrence; (3) modafinil — mixed evidence but actively studied at Mount Sinai, Columbia, NYU; (4) naltrexone + bupropion combination — early evidence of effectiveness; (5) disulfiram (yes, the alcohol medication — affects dopamine metabolism, studied for cocaine). NY academic programs (Mount Sinai REACH, Columbia COMPASS, NYU CAMP, Weill Cornell Addiction Medicine, Albert Einstein College of Medicine, Columbia Mailman School of Public Health) offer clinical trials for stimulant use disorder, which can provide free access to experimental medications with full monitoring. Ask addiction medicine clinicians about trial availability or off-label prescribing.
How does Timothy's Law apply to cocaine treatment in New York?
Timothy's Law (2006) requires all NY group health insurance plans to cover mental health and substance use disorder treatment — including stimulant use disorders like cocaine — at parity with medical/surgical benefits. Combined with NY Article 49 Insurance Law (requires ASAM-aligned medical necessity for all SUD including stimulant), the 2024 NY Medicaid reimbursement parity expansion (commercial insurers must pay OASAS-certified providers at Medicaid-minimum rates), and the 2024 federal MHPAEA final rule (NQTL comparability requirements), NY cocaine patients have strong layered parity protections. These laws prevent arbitrary day caps on residential treatment, ensure coverage of evidence-based interventions including contingency management, and require ASAM-aligned medical necessity determinations.